• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Radiopharmaceutical supply disruptions and the use of Tc-hydroxymethylene diphosphonate as an alternative to Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement.

作者信息

Miller Edward J, Campisi Roxana, Shah Nishant R, McMahon Sean, Cuddy Sarah, Gallegos-Kattan Cesia, Maurer Mathew S, Damy Thibaud, Slart Riemer H J A, Bhatia Ketan, Einstein Andrew J

机构信息

Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.

Diagnóstico Maipú and Instituto Argentino de Diagnóstico y Tratamiento S.A, Buenos Aires, Argentina.

出版信息

J Nucl Cardiol. 2022 Oct;29(5):2748-2760. doi: 10.1007/s12350-022-03059-5. Epub 2022 Jul 15.

DOI:10.1007/s12350-022-03059-5
PMID:35838892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9285188/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/9285188/5837e163e3ff/12350_2022_3059_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/9285188/7ec3080907ec/12350_2022_3059_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/9285188/9b234de407fb/12350_2022_3059_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/9285188/5837e163e3ff/12350_2022_3059_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/9285188/7ec3080907ec/12350_2022_3059_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/9285188/9b234de407fb/12350_2022_3059_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/9285188/5837e163e3ff/12350_2022_3059_Fig3_HTML.jpg

相似文献

1
Radiopharmaceutical supply disruptions and the use of Tc-hydroxymethylene diphosphonate as an alternative to Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement.放射性药物供应中断以及使用锝-羟基亚甲基二膦酸盐替代锝-焦磷酸盐用于转甲状腺素蛋白心脏淀粉样变的诊断：一份美国核医学与分子影像学会信息声明。
J Nucl Cardiol. 2022 Oct;29(5):2748-2760. doi: 10.1007/s12350-022-03059-5. Epub 2022 Jul 15.
2
Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.两例野生型转甲状腺素蛋白心脏淀粉样变性的尸检病例，患者在99m锝-焦磷酸盐闪烁扫描后10天死亡。
J Nucl Cardiol. 2023 Oct;30(5):2215-2221. doi: 10.1007/s12350-022-03128-9. Epub 2022 Nov 9.
3
A case of disappearing amyloid on technetium pyrophosphate scan.锝焦磷酸盐扫描中淀粉样蛋白消失的病例报告。
J Nucl Cardiol. 2023 Oct;30(5):1986-1991. doi: 10.1007/s12350-023-03316-1. Epub 2023 Jun 20.
4
Validation of the Kumamoto criteria for prediction of technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.验证熊本标准对锝焦磷酸盐闪烁扫描阳性的预测作用作为诊断转甲状腺素蛋白心脏淀粉样变的策略：高知县的一项回顾性队列研究。
J Cardiol. 2021 Feb;77(2):124-130. doi: 10.1016/j.jjcc.2020.06.019. Epub 2020 Oct 22.
5
Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.⁹⁹ᵐTc-DPD心肌闪烁显像在心脏淀粉样变性亚型鉴别诊断中的作用。
Rev Esp Cardiol (Engl Ed). 2012 May;65(5):440-6. doi: 10.1016/j.recesp.2011.12.015. Epub 2012 Mar 30.
6
Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.心脏和肝脏淀粉样变性：锝-99m焦磷酸盐与锝-99m亚甲基二膦酸盐检测的比较
Radiology. 1983 Jul;148(1):239-42. doi: 10.1148/radiology.148.1.6304810.
7
Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis.疑似心脏淀粉样变性患者的定量焦磷酸锝和心血管磁共振成像。
J Nucl Cardiol. 2022 Oct;29(5):2679-2690. doi: 10.1007/s12350-021-02806-4. Epub 2021 Oct 3.
8
Alternative Isotope Options for Amyloidosis Imaging: A Technologist's Perspective.用于淀粉样变性成像的替代同位素选择：技术专家的视角。
J Nucl Med Technol. 2023 Jun;51(2):117-119. doi: 10.2967/jnmt.122.264895. Epub 2023 May 16.
9
Tc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis.Tc 骨亲合示踪剂心肌闪烁显像：在转甲状腺素蛋白心脏淀粉样变性的无创性诊断中的作用。
Radiology. 2023 Feb;306(2):e221082. doi: 10.1148/radiol.221082. Epub 2022 Dec 20.
10
In the thick of it: hereditary cardiac amyloidosis identified by I-AT-01 PET imaging but not cardiac MRI or SPECT Tc pyrophosphate scintigraphy.深陷其中：通过I-AT-01正电子发射断层显像（PET）成像而非心脏磁共振成像（MRI）或锝焦磷酸盐单光子发射计算机断层扫描（SPECT）发现的遗传性心脏淀粉样变性。
J Nucl Cardiol. 2023 Jun;30(3):1258-1262. doi: 10.1007/s12350-023-03267-7. Epub 2023 May 3.

引用本文的文献

1
Transthyretin cardiac amyloidosis: advances and ambiguities.转甲状腺素蛋白心脏淀粉样变性：进展与争议
Heart Fail Rev. 2025 Aug 29. doi: 10.1007/s10741-025-10552-9.
2
Advances in Cardiac Imaging and Genetic Testing for Diagnosis and Risk Stratification in Cardiomyopathies: 2024 Update.心肌病诊断与风险分层的心脏成像和基因检测进展：2024年更新
J Clin Med. 2024 Nov 26;13(23):7166. doi: 10.3390/jcm13237166.
3
The Role of Multimodality Imaging in Cardiomyopathy.多模态影像学在心肌病中的作用。

本文引用的文献

1
Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients.肺 99mTc-HMDP 摄取与转甲状腺素心脏淀粉样变患者的限制性通气缺陷和肺电抗异常相关。
Respir Res. 2022 Mar 27;23(1):72. doi: 10.1186/s12931-022-01995-x.
2
Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities.放射性药物剂量测定的报销途径：现状与未来机遇。
J Nucl Med. 2021 Dec;62(Suppl 3):48S-59S. doi: 10.2967/jnumed.121.262752.
3
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
Curr Cardiol Rep. 2024 Jul;26(7):689-703. doi: 10.1007/s11886-024-02068-9. Epub 2024 May 16.
4
Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.在 SCAN-MP 研究中：前 379 例，焦磷酸盐显像上心外摄取的发生率和意义。
J Nucl Cardiol. 2023 Dec;30(6):2531-2539. doi: 10.1007/s12350-023-03310-7. Epub 2023 Jun 13.
美国核医学与分子影像学会/美国心脏协会/美国超声心动图学会/欧洲核医学协会/美国心力衰竭学会/国际淀粉样变性学会/心血管磁共振学会/美国核医学与分子影像学会心脏淀粉样变性多模态成像专家共识建议增编：第1部分，共2部分 - 成像的证据基础和标准化方法
J Nucl Cardiol. 2021 Aug;28(4):1769-1774. doi: 10.1007/s12350-020-02455-z. Epub 2021 Jul 1.
4
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.心脏淀粉样变性的诊断与治疗。欧洲心脏病学会心肌和心包疾病工作组立场声明。
Eur J Heart Fail. 2021 Apr;23(4):512-526. doi: 10.1002/ejhf.2140. Epub 2021 Apr 7.
5
Quantitation of myocardial Tc-HMDP uptake with new SPECT/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use?新型 SPECT/CT 碲锌镉（CZT）相机检测转甲状腺素蛋白相关心脏淀粉样变患者心肌 Tc-HMDP 摄取：是否准备好临床应用？
J Nucl Cardiol. 2022 Apr;29(2):506-514. doi: 10.1007/s12350-020-02274-2. Epub 2020 Jul 26.
6
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.锝-99m 标记骨靶向示踪剂心肌闪烁显像用于疑似淀粉样变性：美国心脏病学会评论期刊本周专题。
J Am Coll Cardiol. 2020 Jun 9;75(22):2851-2862. doi: 10.1016/j.jacc.2020.04.022.
7
Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT.焦磷酸盐核素扫描技术在心脏淀粉样变性中的应用：1 小时与 3 小时成像、平面与 SPECT/CT 比较。
J Nucl Cardiol. 2020 Oct;27(5):1802-1807. doi: 10.1007/s12350-020-02139-8. Epub 2020 May 15.
8
Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.利用骨扫描结合超声心动图及临床相关性评估澳大利亚亚人群中甲状腺转运蛋白（ATTR）心脏淀粉样变的患病率。
J Nucl Cardiol. 2021 Dec;28(6):2845-2856. doi: 10.1007/s12350-020-02152-x. Epub 2020 May 8.
9
Extracardiac soft tissue uptake, evidenced on early Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value.早期Tc-HMDP SPECT/CT显示的心外软组织摄取有助于心脏淀粉样变性的分型，并具有较高的预后价值。
Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2396-2406. doi: 10.1007/s00259-020-04753-7. Epub 2020 Mar 10.
10
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.骨闪烁显像检测 Phe64Leu 突变相关转甲状腺素蛋白心脏淀粉样变的灵敏度低。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1314-1321. doi: 10.1016/j.jcmg.2019.10.015. Epub 2019 Dec 18.